BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 37622313)

  • 1. Prognostic Prediction Value and Biological Functions of Non-Apoptotic Regulated Cell Death Genes in Lung Adenocarcinoma.
    Li HL; Wang JX; Dai HW; Liu JJ; Liu ZY; Zou MY; Zhang L; Wang WR
    Chin Med Sci J; 2023 Sep; 38(3):178-190. PubMed ID: 37622313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Significance and Immunologic Landscape of a Five-IL(R)-Based Signature in Lung Adenocarcinoma.
    Fan T; Pan S; Yang S; Hao B; Zhang L; Li D; Geng Q
    Front Immunol; 2021; 12():693062. PubMed ID: 34497605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction and validation of a prognostic model for lung adenocarcinoma based on endoplasmic reticulum stress-related genes.
    Li F; Niu Y; Zhao W; Yan C; Qi Y
    Sci Rep; 2022 Nov; 12(1):19857. PubMed ID: 36400857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic and onco-immunological value of immune-related eRNAs-driven genes in lung adenocarcinoma.
    Wu X; Zhao X; Zhou C; Wei N; Xu Z; Zhang X
    J Cancer Res Clin Oncol; 2024 Apr; 150(4):188. PubMed ID: 38602568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and Validation of an Inflammatory Response-Related Gene Signature for Predicting the Prognosis of Pancreatic Adenocarcinoma.
    Deng ZL; Zhou DZ; Cao SJ; Li Q; Zhang JF; Xie H
    Inflammation; 2022 Aug; 45(4):1732-1751. PubMed ID: 35322324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of metabolism-related gene signature in lung adenocarcinoma.
    Wang N; Wang H
    Medicine (Baltimore); 2023 Nov; 102(47):e36267. PubMed ID: 38013279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular map of disulfidptosis-related genes in lung adenocarcinoma: the perspective toward immune microenvironment and prognosis.
    Zhao F; Su L; Wang X; Luan J; Zhang X; Li Y; Li S; Hu L
    Clin Epigenetics; 2024 Feb; 16(1):26. PubMed ID: 38342890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a necroptosis-related gene signature for making clinical predictions of the survival of patients with lung adenocarcinoma.
    Zhou X; Zhao M; Fan Y; Xu Y
    PeerJ; 2024; 12():e16616. PubMed ID: 38213773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of prognostic gene signature associated with microenvironment of lung adenocarcinoma.
    Yue C; Ma H; Zhou Y
    PeerJ; 2019; 7():e8128. PubMed ID: 31803536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Intratumor Heterogeneity-Related Signature for Predicting Prognosis, Immune Landscape, and Chemotherapy Response in Colon Adenocarcinoma.
    Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Xie Y
    Front Med (Lausanne); 2022; 9():925661. PubMed ID: 35872794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel transcriptomic signature associated with lymphovascular invasion predicts clinical outcomes, tumor microenvironment, and therapeutic response in lung adenocarcinoma.
    Huang X; Feng Y; Li Y; Ding H; Huang X; Chen C; Yu Z; Zhang J; Xu X; Ma D; Yu S; Chen C
    Int Immunopharmacol; 2024 Jan; 127():111286. PubMed ID: 38064818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cuproptosis-related lncRNA predict prognosis and immune response of lung adenocarcinoma.
    Wang F; Lin H; Su Q; Li C
    World J Surg Oncol; 2022 Sep; 20(1):275. PubMed ID: 36050740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and validation of a novel prognostic model of inflammation-related gene signature of lung adenocarcinoma.
    Luo D; Feng W; Ma Y; Jiang Z
    Sci Rep; 2022 Aug; 12(1):14729. PubMed ID: 36042374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Construction and Validation of Prognostic Risk Score Model of Autophagy Related Genes in Lung Adenocarcinoma].
    Zhou J; Wang X; Li Z; Jiang R
    Zhongguo Fei Ai Za Zhi; 2021 Aug; 24(8):557-566. PubMed ID: 34256900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction of the optimization prognostic model based on differentially expressed immune genes of lung adenocarcinoma.
    Zhai Y; Zhao B; Wang Y; Li L; Li J; Li X; Chang L; Chen Q; Liao Z
    BMC Cancer; 2021 Mar; 21(1):213. PubMed ID: 33648465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognosis-related autophagy genes in female lung adenocarcinoma.
    Liu Z; Zhang K; Zhao Z; Qin Z; Tang H
    Medicine (Baltimore); 2022 Jan; 101(1):e28500. PubMed ID: 35029906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of Spliceosome-Related Genes in the Prediction of Prognosis and Treatment Strategies for Lung Adenocarcinoma.
    Yang Y; Huang T; Fan Y; Lu H; Shao J; Wang Y; Shen A
    Biomed Res Int; 2022; 2022():1753563. PubMed ID: 36389112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive analysis of co-expressed genes with TDP-43: prognostic and therapeutic potential in lung adenocarcinoma.
    Zhang H; Lin J; Yahaya BH
    J Cancer Res Clin Oncol; 2024 Jan; 150(2):44. PubMed ID: 38281298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a glycolysis- and lactate-related gene signature for predicting prognosis, immune microenvironment, and drug candidates in colon adenocarcinoma.
    Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Peng J; Xie Y
    Front Cell Dev Biol; 2022; 10():971992. PubMed ID: 36081904
    [No Abstract]   [Full Text] [Related]  

  • 20. Prognostic model and immunotherapy prediction based on molecular chaperone-related lncRNAs in lung adenocarcinoma.
    Xu Y; Tao T; Li S; Tan S; Liu H; Zhu X
    Front Genet; 2022; 13():975905. PubMed ID: 36313456
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.